Current Approaches to the Prophylaxis of Migraine

Massimo Leone, Gennaro Bussone

Research output: Contribution to journalArticlepeer-review


Migraine is a prevalent and often debilitating condition. Because of this, effective prophylaxis to prevent the recurrence of attacks is an advantageous approach to therapy for some patients. Five main classes of prophylactic agents are currently employed: β-blockers, calcium antagonists, serotonin (5-hydroxytryptamine; 5-HT) modulators, non-steroidal anti-inflammatory drugs and ergot alkaloids. Many variables influence the choice of therapy, including the different characteristics of the available drugs and of each patient. Although β-blockers and flunarizine are generally the most effective prophylactic agents, there is no drug of first-choice and the agent chosen must be carefully tailored to the needs of the individual patient. Status migrainosus — prolonged unresponsive migraine attacks — requires, in most patients, a specific administration protocol consisting of dihydroergot-amine, steroids and phenothiazines.

Original languageEnglish
Pages (from-to)165-173
Number of pages9
JournalCNS Drugs
Issue number3
Publication statusPublished - 1995

ASJC Scopus subject areas

  • Clinical Neurology
  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Pharmacology
  • Neuropsychology and Physiological Psychology


Dive into the research topics of 'Current Approaches to the Prophylaxis of Migraine'. Together they form a unique fingerprint.

Cite this